Skip to main content
SpringerLink
Log in

Considering the Economy of DSM Alternatives

  • Chapter
  • First Online:
Making the DSM-5

Abstract

Criticisms of the DSMs over the past 30 years have rarely generated credible alternative classifications of psychopathology, and virtually all rivals have fallen away, as judged by clinical or research impact. This chapter considers why this has been the case. After some historical context-setting, I propose and defend the following thesis: The DSM prevails because it is, by historical default, entrapped within a “mental health medical-industrial complex (MHMIC)” in which alternatives are economically locked out. The MHMIC as described here consists of ten elements which converge fiscal interests and constrain mental health funding with respect to those interests. This constraint tends to lock the description of psychopathology into a preserve-the-status-quo stance described by Frances and Pincus in the DSM-IV era. The support for this thesis will be graphically displayed through a portrayal of vectors of financial interest involving these stakeholders. The subjugation of scientific, conceptual, or humanistic interests to economic interests is the result, and DSM “pragmatism” will be redescribed as a literal economy of means.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington: American Psychiatric Association; 1980.

    Google Scholar 

  2. Wallace ER. Psychiatry and its nosology: a historico-philosophical overview. In: Sadler JZ, Wiggins OP, Schwartz MA, editors. Philosophical perspectives on psychiatric diagnostic classification. Baltimore: The Johns Hopkins University Press; 1994. p. 16–86.

    Google Scholar 

  3. Sadler JZ. Descriptions and prescriptions: values, mental disorders, and the DSMs. Baltimore: The Johns Hopkins University Press; 2002.

    Google Scholar 

  4. Sadler JZ. Values and psychiatric diagnosis. Oxford/New York: Oxford University Press; 2005.

    Google Scholar 

  5. Charland LC. A madness for identity: psychiatric labels, consumer autonomy, and the perils of the Internet. PPP. 2004;11(4):335–49.

    Google Scholar 

  6. Schwartz MA, Wiggins OP. The hegemony of the DSMs. In: Sadler JZ, editor. Descriptions and prescriptions: values, mental disorders, and the DSMs. Baltimore: The Johns Hopkins University Press; 2002. p. 199–209.

    Google Scholar 

  7. Frances AJ, First MB, Pincus H. DSM-IV guidebook: the essential companion to the diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association; 1995.

    Google Scholar 

  8. World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.

    Google Scholar 

  9. Sadler JZ, Wiggins OP, Schwartz MA, editors. Philosophical perspectives on psychiatric diagnostic classification. Baltimore: The Johns Hopkins University Press; 1994.

    Google Scholar 

  10. Beutler LE, Malik ML, editors. Rethinking the DSM: a psychological perspective. Washington: American Psychological Association; 2002.

    Google Scholar 

  11. Horwitz AV. Creating mental illness. Chicago: University of Chicago Press; 2002.

    Google Scholar 

  12. Zachar P. Psychological concepts and biological psychiatry: a philosophical analysis. Amsterdam: J. Benjamins; 2000.

    Google Scholar 

  13. Jensen PS, Knapp P, Mrazek DA. Toward a new diagnostic system for child psychopathology: moving beyond the DSM. New York: Guilford; 2006.

    Google Scholar 

  14. Cooper R. Classifying madness. A philosophical examination of the diagnostic and statistical manual of mental disorders. New York: Springer; 2005.

    Google Scholar 

  15. Cooper R. Psychiatry and the philosophy of science. Montreal: McGill-Queen’s University Press; 2007.

    Google Scholar 

  16. Murphy D. Psychiatry in the scientific image. Cambridge: MIT; 2006.

    Google Scholar 

  17. Phillips J, First M. DSM-5 in the homestretch–1. Integrating the coding systems. Psychiatr Times [Internet], March 7. 2012. http://www.psychiatrictimes.com/blog/phillips/content/article/10168/2043461.

  18. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association; 1994.

    Google Scholar 

  19. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition, text revision (DSM-IV-TR). Washington: American Psychiatric Association; 2000.

    Book  Google Scholar 

  20. American Psychological Association Task Force on Descriptive Behavioral Classification. Progress Report; July 1977. (Thanks to Dr. Roger K. Blashfield for this document).

    Google Scholar 

  21. Spitzer RL. Nonmedical myths and DSM-III. APA Monitor. 1981 Oct; 3:33.

    Google Scholar 

  22. Smith D, Kraft WA. DSM-III: do psychologists really want an alternative? Am Psychol. 1983;38(7):777–85.

    Article  PubMed  CAS  Google Scholar 

  23. Tsuang MT, Stone WS, Faraone SV. Toward reformulating the diagnosis of schizophrenia. Am J Psychiatry. 2000;157(7):1041–50.

    Article  PubMed  CAS  Google Scholar 

  24. Tsuang MT, Faraone SV, Lyons MJ. Identification of the phenotype in psychiatric genetics. Eur Arch Psychiatry Clin Neurosci. 1993;243(3–4):131–42.

    Article  PubMed  CAS  Google Scholar 

  25. Follette WC. Introduction to the special section on the development of theoretically coherent alternatives to the DSM system. J Consult Clin Psychol. 1996;64(6):1117–9.

    Article  PubMed  CAS  Google Scholar 

  26. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003;160(4):636–45.

    Article  PubMed  Google Scholar 

  27. Walters JT, Owen MJ. Endophenotypes in psychiatric genetics. Mol Psychiatry. 2007; 12(10):886–90.

    Article  PubMed  CAS  Google Scholar 

  28. Hyman SE. Can neuroscience be integrated into the DSM-V? Nat Rev Neurosci. 2007; 8:725–32.

    Article  PubMed  CAS  Google Scholar 

  29. Hyman SE, Fenton WS. Medicine. What are the right targets for psychopharmacology? Science. 2003;299(5605):350–1.

    Article  PubMed  CAS  Google Scholar 

  30. Insel TR, Wang PS. Rethinking mental illness. JAMA. 2010;303(19):1970–1.

    Article  PubMed  CAS  Google Scholar 

  31. National Institute of Mental Health. NIMH strategic plan. Bethesda: National Institute of Mental Health; 2008.

    Google Scholar 

  32. National Institute of Mental Health. RDoC Draft 3.1 June 2011 [Internet]. June 201l. http://www.nimh.nih.gov/research-funding/rdoc/nimh-research-domain-criteria.

  33. Sadler JZ. Psychiatric molecular genetics and the ethics of social promises. J Bioeth Inq. 2011;8:27–34.

    Article  PubMed  Google Scholar 

  34. US Government. Public papers of the Presidents, Dwight D. Eisenhower. [Internet] 1960, p 1035–40. http://quod.lib.umich.edu/p/ppotpus/4728424.1960.001/1090?page=root;rgn=full+text;size=100;view=image. Accessed 2012 June 15.

  35. Healy B. 2005. Quotation in US News & World Report [Internet]. 2005. http://health.usnews.com/usnews/health/articles/050124/24healy.Accessed 2012 June 15.

  36. Kovel J. The American mental health industry. In: Ingleby D, editor. Critical psychiatry: the politics of mental health. New York: Pantheon; 1980. p. 72–101.

    Google Scholar 

  37. Sadler JZ, Jotterand F, Lee SC, Inrig S. Can medicalization be good? Situating medicalization within bioethics. Theor Med Bioeth. 2009;30:411–25.

    Article  PubMed  Google Scholar 

  38. Phillips J, editor. Philosophical perspectives on technology and psychiatry. Oxford: Oxford University Press; 2009.

    Google Scholar 

  39. Pincus H, Frances A, Davis WW, First M, Widiger T. DSM-IV and new diagnostic categories: holding the line on proliferation. Am J Psychiatry. 1992;149(1):112–7.

    PubMed  CAS  Google Scholar 

  40. Lane C. Shyness: how normal behavior became a sickness. New Haven: Yale University Press; 2008.

    Google Scholar 

  41. Horwitz AV, Wakefield JC. The loss of sadness: how psychiatry transformed normal sorrow into depressive disorder. New York/Oxford: Oxford University Press; 2007.

    Google Scholar 

  42. Cosgrove L, Krimsky S, Vijayaraghavan M, Schneider L. Financial ties between DSM-IV panel members and the pharmaceutical industry. Psychother Psychosom. 2006;75:154–60.

    Article  PubMed  Google Scholar 

  43. Cosgrove L, Bursztajn HJ, Krimsky S, Anaya M, Walker J. Conflicts of interest and disclosure in the American Psychiatric Association’s Clinical Practice Guidelines. Psychother Psychosom. 2009;78:228–32.

    Article  PubMed  Google Scholar 

  44. Cosgrove L, Krimsky S. A comparison of DSM-IV and DSM-5 panel members financial associations with industry: a pernicious problem persists. PLoS Med. 2009;9(3):e1001190.

    Article  Google Scholar 

  45. Parens E, Johnston J. Troubled children: diagnosing, treating, and attending to context. Special report. Hastings Cent Rep. 2011;41(2):S1–32.

    Article  PubMed  Google Scholar 

  46. Blendon RJ, Benson JM. Americans’ views on health policy: a fifty-year historical perspective. Health Aff. 2001;20(2):33–46.

    Article  CAS  Google Scholar 

  47. Iglehart JK. Health policy report: the American health care system: medicare. N Engl J Med. 1992;327:1467–72.

    Article  PubMed  CAS  Google Scholar 

  48. Iglehart JK. Rallying the caucus—The Democrats struggle for unity on reform. N Engl J Med. 2009;361:e64.

    Article  PubMed  Google Scholar 

  49. Sparer M. Medicaid and the U.S. path to national health insurance. N Engl J Med. 2009;360:323–5.

    Article  PubMed  CAS  Google Scholar 

  50. De Tocqueville A. Democracy in America [H. C. Mansfield, D. Winthrop, trans]. Chicago: University of Chicago Press; 2000.

    Google Scholar 

  51. Bellah RN, Madsen R, Sullivan WM, Swidler A, Tipton SM. Habits of the heart: individualism and commitment in American life. Berkeley: University of California Press; 2008.

    Google Scholar 

  52. Landers SH, Sehgal AR. Health care lobbying in the United States. Am J Med. 2004;116(7):474–7.

    Article  PubMed  Google Scholar 

  53. Abraham J. The pharmaceutical industry as a political player. Lancet. 2002;360(9344):1498–502.

    Article  PubMed  Google Scholar 

  54. Citizens United v. Federal Election Commission. 558 U.S. Supreme Court (201). Opinion of Stevens, J.

    Google Scholar 

  55. Harris G. Drug makers are advocacy groups biggest donors. The New York Times 2009 Oct 21.

    Google Scholar 

  56. NAMI. Major foundation and corporate support [Internet]. http://www.nami.org/Content/NavigationMenu/Inform_Yourself/About_NAMI/Governance/Major_Foundation_and_Corporate_Support/NAMI_Corporate_Relations_and_Giving_Policies.htm.

  57. Mental Health America. 2010 Annual report. Alexandria: MHA; 2010.

    Google Scholar 

  58. Donohue JM, Cevasco M, Rosenthal MB. A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med. 2007;357:673–81.

    Article  PubMed  CAS  Google Scholar 

  59. Potter W. Deadly spin: an insurance company insider speaks out on how corporate PR is killing health care and deceiving Americans. New York: Bloomsbury; 2009.

    Google Scholar 

  60. Grob GN. The mad among us: a history of the care of America’s mentally ill. New York: Free Press; 1994.

    Google Scholar 

  61. Healy D. The creation of psychopharmacology. Cambridge: Harvard University Press; 2002.

    Google Scholar 

  62. Healy D. Let them eat prozac: the unhealthy relationship between the pharmaceutical industry and depression. New York: NYU; 2004.

    Google Scholar 

  63. Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan A-W, Cronin E, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One. 2008;3(8):e3081. doi:doi: 10.1371/journal.pone.0003081.

    Article  PubMed  Google Scholar 

  64. Ghaemi SN. The failure to know what isn’t known: negative publication bias with lamotrigine and a glimpse inside peer review. Evid Based Ment Health. 2009;12:65–8.

    Article  PubMed  CAS  Google Scholar 

  65. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358:252–60.

    Article  PubMed  CAS  Google Scholar 

  66. Zimmerman M. Why are we rushing to publish DSM-IV? Arch Gen Psychiatry. 1988;45(12):1135–8.

    Article  PubMed  CAS  Google Scholar 

  67. Zimmerman M. Is DSM-IV needed at all? Arch Gen Psychiatry. 1990;47(10):974–6.

    Article  PubMed  CAS  Google Scholar 

  68. Devisch I. Co-responsibility: a new horizon for today’s health care? Health Care Anal. 2012;20:139–51.

    Article  PubMed  Google Scholar 

  69. Jones GK, Brewer KL, Garrison HG. Public expectations of survival following cardiopulmonary resuscitation. Acad Emerg Med. 2000;7(1):48–53.

    Article  PubMed  CAS  Google Scholar 

  70. Rosenberg CE. Disease and social order in America: perceptions and expectations. Milbank Q. 1986;64 Suppl 1:34–55.

    Article  PubMed  Google Scholar 

  71. Scott TL, Gazmararian JA, Williams MV, Baker DW. Health literacy and preventive health care use among medicare enrollees in a managed care organization. Med Care. 2002;40(5):395–404.

    Article  PubMed  Google Scholar 

  72. Shieh C, Halstead JA. Understanding the impact of health literacy on women’s health. J Obstet Gynecol Neonatal Nurs. 2009;38(5):601–10.

    Article  PubMed  Google Scholar 

  73. Williams MV, Davis T, Parker RM, Weiss BD. The role of health literacy in patient-physician communication. Fam Med. 2002;34(5):383–9.

    PubMed  Google Scholar 

  74. Sadler JZ. The instrument metaphor, hyponarrativity, and the generic clinician. In: Phillips J, editor. Philosophical perspectives on technology and psychiatry. Oxford: Oxford University Press; 2009. p. 23–33.

    Google Scholar 

  75. Light DW. Toward a new sociology of medical education. J Health Soc Behav. 1988;29:307–22.

    Article  PubMed  CAS  Google Scholar 

  76. Starr P. The social transformation of American medicine. The rise of a sovereign profession and the making of a vast industry. New York: Basic Books; 1982.

    Google Scholar 

  77. Rothman D, editor. Combating conflict of interest: a primer for countering industry marketing. New York: Institute on Medicine as a Profession; 2012.

    Google Scholar 

  78. Guyatt G et al. Evidence based medicine: a new approach to teaching the practice of medicine. J Am Med Assoc. 1992;268(17):2420–5.

    Article  Google Scholar 

  79. Sackett DL, Rosenberg WMC, Muir Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ. 1996;312:71.

    Article  PubMed  CAS  Google Scholar 

  80. Gupta M. Does evidence based medicine apply to psychiatry? Theor Med Bioeth. 2007; 28:103–20.

    Article  PubMed  Google Scholar 

  81. Blashfield R. Taxonomy of psychopathology blog [Internet]. http://taxonpsych.blogspot.com/.

  82. Kendler KS, Appelbaum PS, Bell CC, Fulford KWM, Ghaemi SN, Schaffner KF, et al. Editorial: Issues for DSM-V: DSM-V should include a conceptual issues work group. Am J Psychiatry. 2008;165(2):174–5.

    Article  PubMed  Google Scholar 

  83. National Institutes of Health. HHS tightens financial conflict of interest rules for researchers [Internet]. 2011. http://www.nih.gov/news/health/aug2011/od-23.htm.

  84. Relman AS. A second opinion: rescuing America’s health care. New York: Public Affairs; 2007.

    Google Scholar 

  85. National Advisory Mental Health Council’s Workgroup. From discovery to cure: accelerating the development of new and personalized interventions for mental illnesses. Bethesda: National Institute of Mental Health; 2010.

    Google Scholar 

  86. Sadler JZ, Fulford KWM. Should patients and families contribute to the DSM-V process? Psychiatr Serv. 2004;55(2):133–8.

    Article  PubMed  Google Scholar 

  87. Frances A. Wonderful news: DSM-5 finally begins its belated and necessary retreat. Psychiatr Times [Internet]. 2012 [2012 May 4]. ­http://www.psychiatrictimes.com/blog/frances/content/article/10168/2068571

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, TX, USA

    John Z. Sadler MD

Authors
  1. John Z. Sadler MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John Z. Sadler MD .

Editor information

Editors and Affiliations

  1. Jewish General Hospital, Department of Psychiatry, Sir Mortimer B. Davis, Côte Ste. Catherine Road 4333, Montreal, H3T1E4, Québec, Canada

    Joel Paris

  2. , Department of Psychiatry, Yale School of Medicine, Noble Avenue 88, New Haven, 06460, Connecticut, USA

    James Phillips

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sadler, J.Z. (2013). Considering the Economy of DSM Alternatives. In: Paris, J., Phillips, J. (eds) Making the DSM-5. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6504-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6504-1_2

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6503-4

  • Online ISBN: 978-1-4614-6504-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation